“…Although not a main focus in the current study, an increasingly common scenario involves combining data from various cohorts and scanners, which poses additional challenges related to site‐ and scanner‐dependent variance (Alfaro‐Almagro et al, 2021 ; Solanes et al, 2021 ; Tønnesen et al, 2020 ). Improving methods for site/scanner adjustments (Bayer et al, 2021 ; Dinga, Schmaal, Penninx, Veltman, & Marquand, 2020 ), or incorporating uncertainties into the predictions (Hahn et al, 2021 ; Marquand et al, 2019 ), represent promising avenues for further developing robust and valid biomarkers for brain health and disease. As evident from the current results, clear reporting of sample characteristics and model attributes is important to enable accurate interpretation of model performance metrics in future work.…”